RDTC are making a new series of publications available to stakeholders. Our D&T reviews are prepared in response to specific requests, and intended for use by drug and therapeutics groups or equivalent committees, They provide an overview of the evidence on a specific therapeutic question, and support the review of applications to use a treatment in an individual or for a cohort. They are not intended to be used as standalone publications.
For a list of the topics available, visit the D&T reviews page.